Related Experiment Video
Updated: Aug 3, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
J G Gong1, A Costanzo, H Q Yang
1Department of Biology, University of California, San Diego, La Jolla 92093-0322, USA.
Abstract:
Cancer chemotherapeutic agents such as cisplatin exert their cytotoxic effect by inducing DNA damage and activating programmed cell death (apoptosis). The tumour-suppressor protein p53 is an important activator of apoptosis. Although p53-deficient cancer cells are less responsive to chemotherapy, their resistance is not complete, which suggests that other apoptotic pathways may exist. A p53-related gene, p73, which encodes several proteins as a result of alternative splicing, can also induce apoptosis. Here we show that the amount of p73 protein in the cell is increased by cisplatin. This induction of p73 is not seen in cells unable to carry out mismatch repair and in which the nuclear enzyme c-Abl tyrosine kinase is not activated by cisplatin. The half-life of p73 is prolonged by cisplatin and by co-expression with c-Abl tyrosine kinase; the apoptosis-inducing function of p73 is also enhanced by the c-Abl kinase. Mouse embryo fibroblasts deficient in mismatch repair or in c-Abl do not upregulate p73 and are more resistant to killing by cisplatin. Our results indicate that c-Abl and p73 are components of a mismatch-repair-dependent apoptosis pathway which contributes to cisplatin-induced cytotoxicity.
Insights
Cisplatin chemotherapy activates a DNA repair-dependent cell death pathway involving p73 and c-Abl tyrosine kinase. This pathway enhances cancer cell killing, even in the absence of the tumor suppressor p53.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Chemotherapy agents like cisplatin induce cancer cell death via DNA damage and apoptosis.
- The tumor suppressor p53 is a key apoptosis activator, but p53-deficient cells retain some chemotherapy sensitivity, suggesting alternative pathways.
- The p53-related gene p73 also induces apoptosis and may play a role in chemotherapy response.
Purpose of the Study:
- To investigate the role of p73 and its regulation in cisplatin-induced apoptosis.
- To identify mechanisms contributing to chemotherapy resistance in p53-deficient cancer cells.
- To elucidate the involvement of DNA mismatch repair and c-Abl tyrosine kinase in cisplatin cytotoxicity.
Main Methods:
- Treating cancer cells with cisplatin and analyzing p73 protein levels.
- Investigating the effect of mismatch repair deficiency and c-Abl inhibition on p73 induction.
- Assessing the impact of c-Abl tyrosine kinase on p73 stability and function.
- Comparing cisplatin sensitivity in mouse embryo fibroblasts with and without mismatch repair or c-Abl.
Main Results:
- Cisplatin treatment increases p73 protein levels in a manner dependent on mismatch repair and c-Abl activation.
- The half-life and apoptosis-inducing function of p73 are enhanced by cisplatin and c-Abl tyrosine kinase.
- Cells deficient in mismatch repair or c-Abl show reduced p73 upregulation and increased resistance to cisplatin.
- p73 protein is stabilized and activated by c-Abl tyrosine kinase.
Conclusions:
- Cisplatin induces apoptosis through a pathway involving p73 and c-Abl tyrosine kinase.
- This pathway is dependent on DNA mismatch repair, contributing to cisplatin cytotoxicity.
- Understanding this p73/c-Abl axis offers insights into chemotherapy resistance and potential therapeutic strategies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
RNA Polymerase II Accessory Proteins
Abnormal Proliferation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
DNA Damage Can Stall the Cell Cycle
The JAK-STAT Signaling Pathway

